Regulation of antiviral signaling: novel role for TAZ, RAE1 and their interaction
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 529712
Grant search
Key facts
Disease
Disease XStart & end year
2024Known Financial Commitments (USD)
$19,279.89Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Aria AfsharianResearch Location
CanadaLead Research Institution
University of TorontoResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
Pathogen morphology, shedding & natural historySpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
UnspecifiedOccupations of Interest
N/A
Abstract
Viral infections represent a major public health problem as evidenced by the COVID-19 pandemic that killed ;7 million people and caused ;700 million illnesses. Disease prevention by vaccination is a major weapon against this often-deadly infection; however, it requires the continuous development of new vaccines, targeting new viral strains. Another, general way to fight all viral diseases is to boost the body own natural antiviral defenses. It is therefore critical to understand our cell antiviral mechanisms, to define how viruses can suppress it (via so-called avoidance tactics), and to find new ways to enhance such protective systems. Two similar cellular proteins called TAZ and YAP are important molecular switches that regulate the expression of genes involved in growth and differentiation. Recently, however, a new and direct (non-genetic) function of TAZ/YAP has emerged; they are suppressors of antiviral defense mechanisms. While this function may be crucial to terminate the defense when it is not needed anymore, it can also be exploited (hijacked) by viral proteins. Importantly, our lab has discovered that TAZ and YAP contain a region that is similar to viral proteins. Further, this region in viral proteins is critical for the suppression of antiviral defenses. With this scenario in mind, my goal is to define the molecular mechanisms whereby TAZ/YAP, similar to viruses, inhibit antiviral signaling. Using a multitude of cellular and molecular approaches, I will study how various TAZ regions affect various steps of antiviral signaling. The major advance I hope to gain by realizing this project is twofold: these studies will generate new insight into antiviral signaling and will provide us with novel strategies to boost antiviral defenses.